The total number of cosmetic surgeries and minimally invasive treatments remained stable in 2024, showing respective 1% and 3% year-over-year increases, according to the 2024 American Society of Plastic Surgeons Procedural Statistics Report.
Likely due to their affordability and short recovery times, minimally invasive injectable treatments grew 3% in 2024, well over the % increase that surgical cosmetic procedures saw. Injectables, known for their personalization and subtle results, remained a clear favorite. Neuromodulators such as Botox Cosmetic saw a 4% year-over-year increase, maintaining their spot as the top minimally invasive treatment, while hyaluronic acid (HA) fillers grew by 1%. Demand for lip and non-HA fillers remained consistently strong, the statistics show.
Of the more than 28.5 million minimally invasive procedures in 2024, the top five were:
- Neuromodulator injections: 9,883,711 procedures
- Hyaluronic acid (HA) fillers: 5,331,426 procedures
- Skin resurfacing (e.g., dermabrasion, chemical peel, ablative/non-ablative laser, microdermabrasion): 3,703,305 procedures
- Skin treatment (e.g., laser hair removal, IPL treatment, laser tattoo removal, laser treatment of leg veins): 3,112,056 procedures
- Lip augmentation (with injectable materials): 1,449,565 procedures
Of the nearly 1.6 million cosmetic surgical procedures performed in 2024, the top five were:
- Liposuction: 349,728 procedures
- Breast augmentation: 306,196 procedures
- Abdominoplasty: 171,064 procedures
- Breast lift: 153,616 procedures
- Blepharoplasty: 120,755 procedures
Of the more than 1 million reconstructive procedures performed in 2024, the top five were:
- Tumor removal (including skin cancer): 361,798 procedures
- Hand surgery (i.e., carpal tunnel, arthritis, trigger finger): 208,480 procedures
- Breast reconstruction: 162,579 procedures
- Maxillofacial surgery: 54,747 procedures
- Scar Revision: 54,280 procedures
Injectable Weight Loss Medication Revolution
For the first time, the 2024 ASPS Procedural Statistics Report has measured the prescription of weight loss medications by its members, with more than 800,000 aesthetic patients utilizing them to support their health goals in 2024.
The report found 20% of GLP-1 patients under the care of ASPS Member Surgeons have already undergone plastic surgery, while 39% are considering a surgical procedure and 41% are considering a nonsurgical procedure.
For more information, visit PlasticSurgery.org/Stats2024.
